Effect of relaxation on Death Anxiety and Hope

Phase 3

• Conditions: Breast cancer.; Malignant neoplasm of breast

• Registration Number: IRCT20170610034435N8
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 April 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Breast Cancer
Ability to communicate in Persian
History of taking anti-anxiety medications
History of participation in training courses (before and during the research)

Exclusion Criteria

History of neurologic and musculoskeletal disorders, auditory problems, and drug abuse
Unwillingness to continue and lack of cooperation at any time of study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Death anxiety. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Templar death anxiety inventory.

Secondary Outcome Measures

Name	Time	Method
Hope. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Herth hope questionnaire.;Death anxiety. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Templer death anxiety questionnaire.